BioSpace News Archive

Yuyu Pharma and SD BIOSENSOR entered into a Supply Agreement, where Yuyu Pharma will export COVID-19 Test Kits to the Global Market.

BERG, a clinical-stage biotech company that uses artificial intelligence to research diseases and develop innovative treatments, announced an agreement to tap the revolutionary Summit supercomputer at the Department of Energy’s Oak Ridge National Laboratory for rapid drug discovery research in the fight against COVID-19.

The CO 2 RE laser platform offers women a nonsurgical, hormone-free treatment for genitourinary syndrome of menopause and stress urinary incontinence MARLBOROUGH, Mass. , June 17, 2020 /PRNewswire/ -- Candela Corporation, a leading global aesthetic device company, today announced that Health Canada has approved the CO 2 RE ® laser, the world’s first fully integrated CO 2

BELFOR Holdings Inc. (BELFOR) , the worldwide leader in property restoration and disaster recovery, today announced that it has entered into a strategic partnership with ViaClean Technologies ,

Olympus®, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announces the commercial launch of the Soltive™ SuperPulsed Laser System (Soltive Laser Syst

Ubiquigent Limited (Ubiquigent) today announced the continuation of a collaboration with Bristol Myers Squibb. The collaboration, originally between Ubiquigent and Celgene, will allow Bristol Myers Squibb to capitalise on the strength and breadth of Ubiquigent’s deubiquitylase (DUB) enzyme inhibitor drug discovery platform and expertise. The central role of ubiquitylation in diverse cellular processes, including pr

IONpath, Inc. the leader in multiplexed spatial tissue imaging and analysis, today announced the appointment of Brad Nelson to the position of Senior Vice President of Marketing and Corporate Strategy. Mr. Nelson will lead marketing, product management and application functions to meet the increasing demand for translational med

Edgewise Therapeutics, a biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, today announced the appointment of Kirsten L. Gruis, M.D., M.S. to the newly created position of Chief Medical Officer. Dr. Gruis will be responsible for leading clinical, medical and

Lantern Pharma to update leading cancer researchers and healthcare professionals on use of artificial intelligence to accelerate development of precision cancer therapies

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies and cancer vaccines, announced today that Dr. Walter Flamenbaum , CEO of AgenTus Therapeutics, and Dr. Marc Van Dijk , Chief Technology Officer of Agenus and AgenTus Therapeutics, will participate in